· 3 min Articles
Clarity enables compliance. Ambiguity drives overcompliance.
FDA’s cybersecurity guidance for medical devices is strong on principle and fuzzy on threshold. That gap does not reduce burden. It moves the interpretation downstream, and companies overbuild to defend themselves.
medical-devicesfdacybersecurityguidance